tiprankstipranks
Trending News
More News >
BeOne Medicines (ONC)
NASDAQ:ONC
US Market

BeOne Medicines (ONC) Financial Statements

Compare
854 Followers

BeOne Medicines Financial Overview

BeOne Medicines's market cap is currently $39.43B. The company's EPS TTM is $0.6; its P/E ratio is 609.83; BeOne Medicines is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $1.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 5.34B$ 3.81B$ 2.46B$ 1.42B$ 1.18B
Gross Profit$ 4.67B$ 3.22B$ 2.08B$ 1.13B$ 1.01B
Operating Income$ 447.14M$ -568.20M$ -1.21B$ -1.79B$ -1.44B
EBITDA$ 616.77M$ -396.44M$ -1.12B$ -1.72B$ -1.39B
Net Income$ 286.93M$ -644.79M$ -881.71M$ -2.00B$ -1.46B
Balance Sheet
Cash & Short-Term Investments$ 4.55B$ 2.63B$ 3.17B$ 4.53B$ 6.62B
Total Assets$ 8.19B$ 5.92B$ 5.81B$ 6.38B$ 8.54B
Total Debt$ 1.09B$ 1.08B$ 930.18M$ 596.67M$ 694.64M
Net Debt$ -3.45B$ -1.55B$ -2.24B$ -3.27B$ -3.68B
Total Liabilities$ 3.83B$ 2.59B$ 2.27B$ 2.00B$ 2.40B
Stockholders' Equity$ 4.36B$ 3.33B$ 3.54B$ 4.38B$ 6.13B
Cash Flow
Free Cash Flow$ 941.74M$ -669.77M$ -1.75B$ -1.97B$ -1.61B
Operating Cash Flow$ 1.13B$ -140.63M$ -1.16B$ -1.50B$ -1.30B
Investing Cash Flow$ -276.15M$ -548.35M$ 60.00M$ 1.08B$ 640.66M
Financing Cash Flow$ 1.06B$ 193.45M$ 416.48M$ -18.97M$ 3.64B
Currency in USD

BeOne Medicines Earnings and Revenue History

BeOne Medicines Debt to Assets

BeOne Medicines Cash Flow

BeOne Medicines Forecast EPS vs Actual EPS